Circulating mutant DNA to assess tumor dynamics-Reference-Cited by-同舟云学术

Circulating mutant DNA to assess tumor dynamics

Published:2008-07-31 Issue:9 Volume:14 Page:985-990
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Diehl Frank,Schmidt Kerstin,Choti Michael A,Romans Katharine,Goodman Steven,Li Meng,Thornton Katherine,Agrawal Nishant,Sokoll Lori,Szabo Steve A,Kinzler Kenneth W,Vogelstein Bert,Diaz Jr Luis A

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.1789.pdf

Reference16 articles.

1. Wood, L.D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108–1113 (2007).

2. Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235–1239 (2007).

3. Cristofanilli, M. et al. Circulating tumor cells, disease progression and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781–791 (2004).

4. Sidransky, D. Emerging molecular markers of cancer. Nat. Rev. Cancer 2, 210–219 (2002).

5. Goebel, G., Zitt, M., Zitt, M. & Muller, H.M. Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Dis. Markers 21, 105–120 (2005).

Cited by 2222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of circulating plasma cell-free DNA for detection and quantification of brain arteriovenous malformations;Nano Today;2024-10

2. Early Diagnostic Markers for Esophageal Squamous Cell Carcinoma: Copy Number Alteration Gene Identification and cfDNA Detection;Laboratory Investigation;2024-10

3. Detection of multiple activating NRAS variants under BRAF/MEK-inhibitor therapy in BRAF positive malignant melanoma using liquid biopsy;JAAD Case Reports;2024-10

4. Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection;eBioMedicine;2024-10

5. Systematic Reversal of Drug Resistance in Cancer;Targets;2024-09-13